In the last trading session, 1.13 million Precigen Inc (NASDAQ:PGEN) shares changed hands as the company’s beta touched 1.60. With the company’s per share price at $1.80 changed hands at $0.06 or 3.45% during last session, the market valuation stood at $527.16M. PGEN’s last price was a discount, traded about -20.56% off its 52-week high of $2.17. The share price had its 52-week low at $0.65, which suggests the last value was 63.89% up since then. When we look at Precigen Inc’s average trading volume, we note the 10-day average is 1.26 million shares, with the 3-month average coming to 2.09 million.
Analysts gave the Precigen Inc (PGEN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.00. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended PGEN as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight.
Precigen Inc (NASDAQ:PGEN) trade information
Instantly PGEN was in green as seen at the end of in last trading. With action -3.23%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 60.71%, with the 5-day performance at -3.23% in the red. However, in the 30-day time frame, Precigen Inc (NASDAQ:PGEN) is -5.76% down. Looking at the short shares, we see there were 21.57 million shares sold at short interest cover period of 9.69 days.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 70.0% from its current market value. According to analyst projections, PGEN’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -233.33% plunge from its current level, while the stock would need to soar -233.33% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 36.94%. The 2025 estimates are for Precigen Inc earnings to decrease by -15.38%.
PGEN Dividends
Precigen Inc is expected to release its next quarterly earnings report on 2024-Nov-13.
Precigen Inc (NASDAQ:PGEN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 9.92% of Precigen Inc shares while 66.34% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 73.65%. There are 66.34% institutions holding the Precigen Inc stock share, with PATIENT CAPITAL MANAGEMENT, LLC the top institutional holder. As of 2024-06-30, the company held 7.2017% of the shares, roughly 18.17 million PGEN shares worth $28.72 million.
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 4.1116% or 10.25 million shares worth $16.19 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Trust for Advised Port-Patient Opportunity Trust and Vanguard Total Stock Market Index Fund . With 14.4 shares estimated at $25.92 million under it, the former controlled 4.92% of total outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held about 1.86% of the shares, roughly 5.45 shares worth around $9.82 million.
